Zilico’s ZedScan Receives CE Mark Approval

by Kathy Jones on  October 8, 2013 at 11:23 PM Medical Gadgets
RSS Email Print This Page Comment bookmark
Font : A-A+

Manchester-based medical device maker Zilico revealed that it has received the CE Mark approval for its cervical cancer diagnostic device, ZedScan.
 Zilico’s ZedScan Receives CE Mark Approval
Zilico’s ZedScan Receives CE Mark Approval

The company had been carrying out trials to test the effectiveness of the device, initially known as APX, over the past few years and said that ZedScan is able to accurately diagnose cervical cancer based on the differences in electrical resistance between normal, pre-cancerous, and cancerous tissue. Apart from being able to accurately diagnose the presence of cancer, a recent independent health economics report has found the device to be cost-effective for healthcare systems, the company said.

"ZedScan has the potential to make a significant impact on how women are managed within the cervical cancer pathway by providing better information to the clinician in real-time and its European approval is an important advancement for clinicians, healthcare systems and patients", Zilico CEO, Sameer Kothari said.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive